Dynamics of plasma thymidine kinase activity in metastatic melanoma reflects immune checkpoint inhibitor efficacy

Acta Oncol. 2022 Sep;61(9):1116-1120. doi: 10.1080/0284186X.2022.2121615. Epub 2022 Sep 9.

Fernanda Costa Svedman^{1

2}, Marie Jalsenius², Vitali Grozman^{3

4}, Mattias Bergqvist⁵, Fabian Söderdahl⁶, Samuel Rotstein², Lars Ny⁷, Suzanne Egyhazi Brage¹, Hildur Helgadottir^{1

2}

¹ Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
² Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
³ Section of Thoracic Radiology, Department of Imaging and Physiology, Karolinska University Hospital, Stockholm, Sweden.
⁴ Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
⁵ Biovica International AB, Uppsala Science Park, Uppsala, Sweden.
⁶ Statisticon AB, Uppsala, Sweden.
⁷ Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.

No abstract available

Publication types